Stock ATHE ALTERITY THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Alterity Therapeutics Limited Nasdaq

Equities

ATHE

US02155X2053

Market Closed - Nasdaq
Other stock markets
 21:30:00 17/05/2024 BST 		5-day change 1st Jan Change
2 USD -0.99% Intraday chart for Alterity Therapeutics Limited -0.50% -19.68%
05-08 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review CI
05-08 Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November MT

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ATH Stock
  4. ATHE Stock
  5. Revisions Alterity Therapeutics Limited